ArticleCancers2022

Tumor Treating Fields Concomitant with Sorafenib in Advanced Hepatocellular Cancer: Results of the HEPANOVA Phase II Study.

Eleni Gkika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.